| Mitchell Scott Parham, | |
|
9003 Milan Ave, Benton, AR 72019-8777 | |
| (870) 329-6557 | |
| Not Available |
| Full Name | Mitchell Scott Parham |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 9003 Milan Ave, Benton, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396346011 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PD09367 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mitchell Scott Parham, Wal Mart Pharmacy 1601 Albert Pike, 1601 Albert Pike, Hot Springs, AR 71913 Ph: (501) 624-0142 | Mitchell Scott Parham, 9003 Milan Ave, Benton, AR 72019-8777 Ph: (870) 329-6557 |
News Archive
Wyeth Pharmaceuticals, a division of Wyeth, and Santaris Pharma have announced that the companies have entered into a worldwide strategic alliance to discover, develop and commercialize new medicines based on Santaris Pharma's proprietary Locked Nucleic Acid (LNA) drug platform, which allows specific targeting and regulation of microRNAs (miRNAs) and messenger RNAs (mRNAs) as a means to affect gene expression mediated by the targeted RNAs.
Results from a late breaking clinical trial called COGENT demonstrate that the combination of giving patients clopidogrel, a blood thinner commonly prescribed to patients with cardiovascular disease, and stomach medicines such as omeprazole, known as proton pump inhibitors (PPIs), did not lead to adverse events, as some prior studies had suggested.
Sortilin, which is a protein expressed on the surface of nerve cells, plays a crucial role in pain development in laboratory mice - and in all likelihood in humans as well.
A University of Texas at Arlington electrical engineering researcher is developing a more efficient, low-power integrated circuit for directional hearing aids that will lead to a better quality of life for hearing impaired people.
Researchers from the US tested the prophylactic potential of a combination of 2 mAbs administered 3 or 75 days before respiratory challenge in rhesus macaques. They used the rhesus macaque model to test the added benefit of combinatory parenteral administration of 2 high-affinity anti-SARS-CoV-2 mAbs - C144-LS and C135-LS. These mAbs were developed to neutralize the virus and tweaked to improve their pharmacokinetics.
› Verified 1 days ago
Jana Spivey White, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17309 I 30, Benton, AR 72015 Phone: 501-778-5041 Fax: 501-315-5044 | |
Dr. Nick L. Landers, P.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 414 N Main St, Benton, AR 72015 Phone: 501-315-7700 Fax: 501-315-4136 | |
Sandra Hawn, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 702 Military Rd, Benton, AR 72015 Phone: 501-860-7372 | |
Kristen Leeann Lovelady, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20820 Interstate 30 N, Benton, AR 72019 Phone: 501-574-3884 | |
Dr. Maddison Elaine Schuller, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 620 W South St, Benton, AR 72015 Phone: 501-778-3151 | |
Dr. Isabelle Diane Reaves, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1016 W South St Ste 1, Benton, AR 72015 Phone: 501-315-5100 Fax: 501-776-1313 | |
Dr. Blake Torres, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 501 W Sevier St, Benton, AR 72015 Phone: 501-778-3151 |